Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established ...

WASHINGTON—U.S. Senator Mike Braun questioned Novo Nordisk CEO, Lars Fruergaard Jørgensen, at the Senate Health, Education, ...

Fewer than two in five U.S. adults (38%) say they will definitely get a flu jab, and only one in four (26%) say they'll get ...

More than 14 million Americans now provide daily care to wounded, sick or injured military service members or veterans, a new ...

Cantor Fitzgerald Managing Director Louise Chen noted that price of weight loss drugs from Novo Nordisk and Eli Lilly should ...

Viking Therapeutics, Inc.'s stock surged 1,500% on the promising obesity drug VK-2735, with Phase 3 trials and potential for ...

Sanders found unlikely common ground with pro-Trump Elon Musk, citing the tech mogul as “right” on “solving obesity” in a ...

The results suggest Ozempic could potentially become a new alternative treatment for opioid use disorder, which could help ...

People with a history of opioid abuse who took Novo Nordisk A/S’s Ozempic were less likely to overdose, according to a study ...

From a moral perspective, does it bother you knowing that keeping the price of Ozempic and Wegovy so high in the United ...

Sen. Bernie Sanders pressed the Novo Nordisk CEO about why the company charges Americans far more than other countries for the same drug.

Novo Nordisk said it’s open to discussions with PBMs based on their commitments that a lower semgalutide list price would not ...